Neuroimaging Study

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT03618186
Phase
PHASE2
Status
Enrolling By Invitation

Conditions

  • Cognitive Impairment

Eligibility Criteria

Sex
ALL
Age
30 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Tau PET scan — COMBINATION_PRODUCT
    Patient will receive a dose of flutaucipir and be scanned appropriately

Study Details

The researchers are trying to gather information and learn more about imaging tests in racially different people who are cognitively normal or have dementia.

Key Dates

Start date
Nov 26, 2018
Status verified
Jun 2025
Primary completion
May 31, 2030
Completion
May 31, 2030

Study Design

Enrollment
240 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Normal control
    Cognitively normal volunteers
  • Experimental: Mild Cogntive impairment
    Person with cognitive impairment that meet Peterson Criteria
  • Experimental: Demented
    Patient's that meet dementia criteria

Primary Outcome Measure

Tau positive scans [ Time Frame: 5 years ]

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-
Mayo Clinic MinnesotaRochesterMinnesota55905-

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FLMayo Clinic Minnesota· Rochester, MN

Related Studies